Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
261studies shown
Showing 217-228 of 261
Drug study icon
CompletedNCT02046369

Lurasidone Pediatric Bipolar Study

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

In France
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugA study involving a medication or substance.From 10 Years to 17 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Other study type icon
CompletedNCT07380074

Mental Health Outcomes and Variations in Exercise in Residents

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.

Remote / online
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.Over 18 Years
Countries
France
Sponsor
University Hospital, Caen
Condition
Anxiety, Depression
Other study type icon
CompletedNCT03424486

Prevalence and Impact of Depression and Anxiety in Cystic Fibrosis

This study exists to see whether smoking support or smoking-related treatment can make care clearer and more responsive. Researchers are trying to understand whether smoking support or smoking-related treatment can better support energy, concentration, and everyday functioning.

In France
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionOtherFrom 14 Years to 17 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
Anxiety, Depression
Drug study icon
TerminatedNCT00622245

Lu AA34893 for depression in bipolarity

This study was terminated in Australia, in France, in Canada, .... It is testing Lu AA34893 for depression in bipolarity.

In France
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
Australia, France, Canada, ...
Sponsor
H. Lundbeck A/S
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2008-007483-42

Lurasidone for depression

This study is completed in France, in Czechia, in Germany, .... It is testing lurasidone for depression.

In France
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionOther
Countries
France, Czechia, Germany, ...
Sponsor
Sunovion Pharmaceuticals Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2008-007457-13

Lurasidone for depression

This study is completed in France, in Czechia, and in Germany. It is testing lurasidone for depression.

In France
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionOther
Countries
France, Czechia, Germany
Sponsor
Sunovion Pharmaceuticals, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2008-007482-23

Lurasidone Adjunctive to Lithium or Divalproex for depression

This study is completed in France, in Czechia, and in Germany. It is testing lurasidone Adjunctive to Lithium or Divalproex for depression.

In France
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionOther
Countries
France, Czechia, Germany
Sponsor
Sunovion Pharmaceuticals, Inc.
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.